Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 32 of Celularity Inc's SEC filings and found 37 warrant series, 5 convertibles, 1 ATM program, 1 equity line, 3 S-1 registrations and 4 completed offerings on file for CELU. The latest dilution event on file is an offering on Sep 24, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
RNAZTransCode Therapeutics, Inc.
EVAXEvaxion A/S American Depositary Share
BYSIBeyondSpring Inc.
BCTXBriaCell Therapeutics Corp.
ABVCABVC BioPharma, Inc.
ALGSAligos Therapeutics, Inc.
NXTCNextCure, Inc.
MBAIMBody AI Ltd.
AARDAardvark Therapeutics, Inc. Common Stock
FLNAFilana Therapeutics, Inc.
PLRZPolyrizon Ltd. Ordinary Shares
CRVOCervoMed Inc.
CVMCEL-SCI Corporation
ATOSAtossa Therapeutics, Inc.
MGXMetagenomi, Inc. Common Stock